Eva Pinilla-Calvo
Valdeolmos, MD 28130, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Triacylglycerol metabolism is a novel target to combat West Nile virus infection.
Journal: Emerging microbes & infections
Published: September 01, 2026
Multivalent Disabled Infectious Single Animal (DISA)-DIVA vaccine for all nine serotypes of African horse sickness virus (AHSV) is broadly protective in IFNAR (-/-) mice.
Journal: Veterinary research
Published: December 12, 2025
Structure-Guided Engineering of Protein VP2 from Epizootic Hemorrhagic Disease Virus Maximizes Production and Confers Complete Protection as Subunit Vaccine.
Journal: Vaccines
Published: November 11, 2025
Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.
Journal: Virology journal
Published: June 20, 2025
The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge.
Journal: NPJ vaccines
Published: February 07, 2025
The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.
Journal: Frontiers in immunology
Published: January 24, 2025
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses.
Journal: Vaccines
Published: December 27, 2024
Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against Epizootic hemorrhagic disease virus in IFNAR(-/-) mice.
Journal: Journal of virology
Published: November 07, 2024
Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus.
Journal: International immunopharmacology
Published: May 30, 2024
Last Updated: 09/26/2026